Clinical trial Recruiting at 1 site Observational Ages 0 and up

Registry for ME/CFS patients in Germany

Official title: Multi-Center Registry for ME/CFS, Including ME/CFS Following Epstein-Barr Virus-Associated Infectious Mononucleosis (EBV-IM) or Coronavirus Disease 2019 (Covid-19)

Run by Technical University of Munich · NCT05778006 · Data updated 2026-11-12

This study is creating a large registry to collect health information from people of all ages with ME/CFS in Germany, especially those affected by long-term COVID-19 effects, to help improve understanding and treatment of the condition.

Quick facts

Study typeObservational
Ages0 Years and up
SexAll
Enrollment650 (estimated)
SponsorTechnical University of Munich
Academic / other
Locations1 site (Munich, Bavaria)
StatusRecruiting
StartedMay 31, 2022
Main results expectedMay 31, 2052
Study endsMay 31, 2052
Registry record updatedJanuary 10, 2025
Trial IDNCT05778006 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals diagnosed with ME/CFS based on internationally recognized criteria.

Probably not a fit

Patients who do not have a diagnosis of ME/CFS or cannot provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to establish a large-scale registry to collect data on the epidemiology, phenotypes, and disease trajectories of ME/CFS in Germany. It focuses on individuals of all ages affected by ME/CFS, particularly in the context of long-term effects following COVID-19 and other viral infections. The registry will facilitate future clinical trials by providing valuable insights into the condition and its management. The study will include patients diagnosed with ME/CFS based on established international criteria and will gather comprehensive health data.

Why it matters

Potential benefit: If successful, this registry could enhance understanding of ME/CFS and lead to improved diagnosis and treatment options for patients.

How similar studies have gone: While there have been various studies on ME/CFS, this registry approach is relatively novel and aims to fill gaps in existing knowledge.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* ME/CFS diagnosis (ICD-10 G93.3) based on internationally established criteria
* Informed consent by patients and/or guardian(s)

Exclusion Criteria:

* No ME/CFS (ICD-10 G93.3)
* No informed consent

Where it's running

  • MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
    Munich, Bavaria, Germany
    Recruiting

Study contacts

  • Principal investigator: Uta Behrends, Prof. Dr. med. — MRI Chronic Fatigue Center for Young People (MCFC) Children's Hospital, Technical University of Munich & Munich Municipal Hospital
  • Study coordinator: Uta Behrends, Prof. Dr. med.
  • Email: uta.behrends@tum.de
  • Phone: +4989 30682632

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.